MARKET

GMED

GMED

Globus Med Inc
NYSE
82.63
+0.69
+0.84%
After Hours: 82.05 -0.59 -0.71% 19:33 12/20 EST
OPEN
81.64
PREV CLOSE
81.94
HIGH
83.27
LOW
81.27
VOLUME
2.83M
TURNOVER
--
52 WEEK HIGH
87.22
52 WEEK LOW
49.14
MARKET CAP
11.25B
P/E (TTM)
124.50
1D
5D
1M
3M
1Y
5Y
1D
This Globus Medical Insider Reduced Their Stake By 100%
Simply Wall St · 1d ago
Is Your Portfolio Missing These 5 High-Growth Healthcare Stocks?
NASDAQ · 1d ago
Piper Sandler Reaffirms Their Buy Rating on Globus Medical (GMED)
TipRanks · 2d ago
16 Analysts Have This To Say About Globus Medical
Benzinga · 2d ago
Globus Medical Is Maintained at Hold by Truist Securities
Dow Jones · 2d ago
Globus Medical Price Target Raised to $90.00/Share From $85.00 by Truist Securities
Dow Jones · 2d ago
Truist Securities Maintains Hold on Globus Medical, Raises Price Target to $90
Benzinga · 2d ago
Globus Medical price target raised to $90 from $85 at Truist
TipRanks · 3d ago
More
About GMED
Globus Medical, Inc. is a medical device company that develops and commercializes healthcare solutions with a focus on improving the quality of life of patients with musculoskeletal disorders. The Company offers a portfolio of differentiated technologies that are used to treat a variety of musculoskeletal conditions. Musculoskeletal Solutions consist primarily of implantable devices, biologics, accessories, and surgical instruments used in a range of spinal, orthopedic and neurosurgical procedures. Its spine products address the majority of conditions affecting the spine, including degenerative conditions, deformity, tumors, and trauma. It provides solutions that facilitate both open and minimally invasive surgery (MIS) techniques. It includes traditional fusion implants, such as pedicle screws and rod systems. Its orthopedic trauma solutions are designed to treat a variety of orthopedic fracture patterns and patient anatomies in the upper and lower extremities, as well as the hip.

Webull offers Globus Medical Inc stock information, including NYSE: GMED real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, GMED stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading GMED stock methods without spending real money on the virtual paper trading platform.